149 related articles for article (PubMed ID: 9783684)
1. Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implications for pathogenesis doubtful.
Searle K; Schalasta G; Enders G
J Med Virol; 1998 Nov; 56(3):192-8. PubMed ID: 9783684
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
Jones LP; Erdman DD; Anderson LJ
J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
[TBL] [Abstract][Full Text] [Related]
4. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection.
Kerr JR; Cunniffe VS
Rheumatology (Oxford); 2000 Aug; 39(8):903-8. PubMed ID: 10952747
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?
Mitchell LA
J Med Virol; 2002 Jun; 67(2):267-74. PubMed ID: 11992589
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19 antibodies induce altered membrane protein expression and apoptosis of BeWo trophoblasts.
Tzang BS; Chiang SY; Chan HC; Liu CH; Hsu TC
Mol Med Rep; 2016 Nov; 14(5):4399-4406. PubMed ID: 27748859
[TBL] [Abstract][Full Text] [Related]
8. [DIAGNOSTIC VALUE OF COMBINED USE OF COMBINED METHOD OF ENZYME IMMUNOASSAY AND POLYMERASE CHAIN REACTION TO DETECT OF INTRAUTERINE FETAL INFECTION BY PARVOVIRUS B19].
Bondarenko NP; Lakatosh VP; Lakatosh PV; Malanchuk OB; Poladich IV
Lik Sprava; 2015; (3-4):121-8. PubMed ID: 26827452
[TBL] [Abstract][Full Text] [Related]
9. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen.
Venturoli S; Gallinella G; Manaresi E; Gentilomi G; Musiani M; Zerbini M
J Infect Dis; 1998 Dec; 178(6):1826-9. PubMed ID: 9815244
[TBL] [Abstract][Full Text] [Related]
10. Detection of parvovirus B19 infection in first and second trimester fetal loss.
de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
12. Risk of perinatal transmission of rubella and parvovirus B19 in Jordanian pregnant women.
Bdour S
Vaccine; 2006 Apr; 24(16):3309-12. PubMed ID: 16460842
[TBL] [Abstract][Full Text] [Related]
13. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
14. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
[TBL] [Abstract][Full Text] [Related]
15. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.
Lehmann HW; Kühner L; Beckenlehner K; Müller-Godeffroy E; Heide KG; Küster RM; Modrow S
J Clin Virol; 2002 Aug; 25(2):135-43. PubMed ID: 12367647
[TBL] [Abstract][Full Text] [Related]
16. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses in parvovirus B19 infected patients.
Modrow S; Dorsch S
Pathol Biol (Paris); 2002 Jun; 50(5):326-31. PubMed ID: 12116851
[TBL] [Abstract][Full Text] [Related]
18. Intra-uterine parvovirus B19 infection and meconium peritonitis.
Zerbini M; Gentilomi GA; Gallinella G; Morandi R; Calvi S; Guerra B; Musiani M
Prenat Diagn; 1998 Jun; 18(6):599-606. PubMed ID: 9664606
[TBL] [Abstract][Full Text] [Related]
19. Parvovirus B19 diagnosis in pregnant women--quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum.
Searle K; Guilliard C; Enders G
Infection; 1997; 25(1):32-4. PubMed ID: 9039535
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 infection in pregnancy studied by maternal viral load and immune responses.
de Haan TR; Beersma MF; Claas EC; Oepkes D; Kroes AC; Walther FJ
Fetal Diagn Ther; 2007; 22(1):55-62. PubMed ID: 17003557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
